Nikorono Frukt (Nicotine)

Nicotine, the active ingredient in Nikorono Frukt, is a nicotinic receptor agonist presented as an oral formulation for smoking cessation use. It helps reduce nicotine withdrawal symptoms and supports individuals who are trying to quit tobacco smoking. The medication is intended for adult patients who have expressed a desire to discontinue nicotine consumption and are seeking a regulated, non‑combustible alternative to aid the quitting process.

GNH USA supplies Nikorono Frukt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nikorono Frukt (nicotine) acts on nicotinic acetylcholine receptors to aid smoking cessation.

- Smoking cessation: reduces withdrawal symptoms and cravings, facilitating quitting. - Tobacco dependence: supports gradual reduction of nicotine intake in dependent individuals. - Nicotine addiction: provides a regulated oral alternative to help manage addiction.

Nikorono Frukt may cause a range of adverse reactions. Patients should be aware of both common and less frequent but serious events.

Common Side Effects: - Nausea or upset stomach. - Mouth or throat irritation. - Headache. - Dizziness or light‑headedness. - Insomnia or sleep disturbances. - Increased heart rate.

Serious or Rare Side Effects: - Hypertension or severe blood pressure elevation. - Cardiac arrhythmias. - Allergic reactions including rash, swelling, or anaphylaxis. - Seizures. - Severe vomiting or dehydration. - Chest pain or signs of myocardial ischemia.

Before initiating therapy, certain precautions should be observed to ensure safe use. - Assess cardiovascular status: evaluate patient history of heart disease before use. - Avoid use in uncontrolled hypertension: monitor blood pressure regularly. - Do not combine with other nicotine products: risk of nicotine overdose. - Use with caution in patients with gastrointestinal disorders: may exacerbate symptoms. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotine can interact with several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive risk. - Beta‑blockers: may blunt cardiovascular response. - CYP2A6 inhibitors: may raise nicotine plasma levels. - Other nicotine replacement therapies: risk of nicotine toxicity. - Alcohol: may enhance nicotine's cardiovascular effects.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): may increase nausea. - Antihypertensives: may require dose adjustment. - Caffeine: may increase jitteriness. - Theophylline: may heighten side‑effects. - Anticholinergic drugs: may reduce nicotine efficacy.